Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Boeing Company stock logo
BA
Boeing
$164.34
-2.9%
$188.03
$162.74
$267.54
$100.27B1.529.75 million shs20.82 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.26
-0.2%
$27.05
$25.23
$40.37
$148.70B0.6141.89 million shs24.50 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Boeing Company stock logo
BA
Boeing
-0.80%-0.81%-10.42%-21.00%-17.79%
Pfizer Inc. stock logo
PFE
Pfizer
+0.23%+2.45%-3.80%-7.09%-34.05%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Boeing Company stock logo
BA
Boeing
4.4691 of 5 stars
4.35.00.00.02.31.71.9
Pfizer Inc. stock logo
PFE
Pfizer
4.995 of 5 stars
3.25.04.24.83.11.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Boeing Company stock logo
BA
Boeing
2.57
Moderate Buy$226.7137.95% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.3338.36% Upside

Current Analyst Ratings

Latest PFE and BA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
The Boeing Company stock logo
BA
Boeing
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$235.00 ➝ $190.00
4/17/2024
The Boeing Company stock logo
BA
Boeing
Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell$140.00
4/16/2024
The Boeing Company stock logo
BA
Boeing
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$225.00 ➝ $215.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/12/2024
The Boeing Company stock logo
BA
Boeing
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$230.00 ➝ $210.00
4/11/2024
The Boeing Company stock logo
BA
Boeing
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$210.00 ➝ $190.00
4/10/2024
The Boeing Company stock logo
BA
Boeing
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$270.00 ➝ $260.00
4/10/2024
The Boeing Company stock logo
BA
Boeing
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$235.00 ➝ $180.00
4/8/2024
The Boeing Company stock logo
BA
Boeing
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$272.00 ➝ $240.00
4/1/2024
The Boeing Company stock logo
BA
Boeing
Melius Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
4/1/2024
The Boeing Company stock logo
BA
Boeing
Melius
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Boeing Company stock logo
BA
Boeing
$77.79B1.29N/AN/A($28.24) per share-5.82
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.54$2.98 per share8.82$15.81 per share1.66

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Boeing Company stock logo
BA
Boeing
-$2.22B-$3.68N/A27.57135.00-2.86%N/A-2.60%4/24/2024 (Confirmed)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3672.949.481.183.62%10.88%4.91%5/1/2024 (Confirmed)

Latest PFE and BA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/24/2024N/A
The Boeing Company stock logo
BA
Boeing
-$1.08-$1.76-$0.68N/A$16.24 billion$16.57 billion    
1/31/2024Q4 2023
The Boeing Company stock logo
BA
Boeing
-$0.72-$0.47+$0.25-$0.90$21.14 billion$22.02 billion      
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Boeing Company stock logo
BA
Boeing
$8.225.00%N/AN/A N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.40%+2.57%466.67%15 Years

Latest PFE and BA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/10/20246/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Boeing Company stock logo
BA
Boeing
N/A
1.14
0.31
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Boeing Company stock logo
BA
Boeing
64.82%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
The Boeing Company stock logo
BA
Boeing
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Boeing Company stock logo
BA
Boeing
171,000610.14 million609.16 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

PFE and BA Headlines

SourceHeadline
Pfizer declares $0.42 dividendPfizer declares $0.42 dividend
msn.com - April 24 at 8:10 PM
Pfizer Inc. (NYSE:PFE) Shares Sold by Alaska Permanent Fund CorpPfizer Inc. (NYSE:PFE) Shares Sold by Alaska Permanent Fund Corp
marketbeat.com - April 24 at 5:28 PM
Pfizer Inc. (NYSE:PFE) to Issue Quarterly Dividend of $0.42Pfizer Inc. (NYSE:PFE) to Issue Quarterly Dividend of $0.42
marketbeat.com - April 24 at 5:22 PM
Pfizer Declares Second-Quarter 2024 DividendPfizer Declares Second-Quarter 2024 Dividend
businesswire.com - April 24 at 4:37 PM
Pfizer (NYSE:PFE) Trading Down 0.5%Pfizer (NYSE:PFE) Trading Down 0.5%
marketbeat.com - April 24 at 4:22 PM
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
zacks.com - April 24 at 1:06 PM
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
zacks.com - April 24 at 11:06 AM
Pfizer gets grant for treatment of cancer using engineered immune cells targeting bcmaPfizer gets grant for treatment of cancer using engineered immune cells targeting bcma
pharmaceutical-technology.com - April 24 at 10:09 AM
6 of the Highest-Yielding S&P 500 Stocks Offer Huge Passive Income6 of the Highest-Yielding S&P 500 Stocks Offer Huge Passive Income
247wallst.com - April 24 at 7:30 AM
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting WealthThe Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
investorplace.com - April 24 at 7:25 AM
Pfizer (PFE) Scheduled to Post Quarterly Earnings on WednesdayPfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - April 24 at 1:58 AM
Pfizer’s Emblaveo receives European marketing approval for patients with multidrug-resistant infections and limited treatment optionsPfizer’s Emblaveo receives European marketing approval for patients with multidrug-resistant infections and limited treatment options
pharmabiz.com - April 24 at 12:08 AM
Pfizer confirms end of Boulder R&D operationsPfizer confirms end of Boulder R&D operations
msn.com - April 24 at 12:08 AM
Pfizer Inc. (NYSE:PFE) Shares Bought by South Dakota Investment CouncilPfizer Inc. (NYSE:PFE) Shares Bought by South Dakota Investment Council
marketbeat.com - April 23 at 8:58 PM
Pfizer to shutter Boulder R&D operationsPfizer to shutter Boulder R&D operations
bizwest.com - April 23 at 7:07 PM
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
investorplace.com - April 23 at 3:00 PM
Pfizer (NYSE:PFE) Shares Up 0.5%Pfizer (NYSE:PFE) Shares Up 0.5%
marketbeat.com - April 23 at 2:58 PM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)
markets.businessinsider.com - April 23 at 2:03 PM
Better Buy: Pfizer vs. Viking TherapeuticsBetter Buy: Pfizer vs. Viking Therapeutics
fool.com - April 23 at 9:15 AM
Pfizer vs Moderna battle over COVID vaccine patents begins in UKPfizer vs Moderna battle over COVID vaccine patents begins in UK
finance.yahoo.com - April 23 at 7:37 AM
Pfizer vs Moderna battle over COVID vaccine patents begins in UKPfizer vs Moderna battle over COVID vaccine patents begins in UK
reuters.com - April 23 at 7:21 AM
New York State Common Retirement Fund Has $281.24 Million Position in Pfizer Inc. (NYSE:PFE)New York State Common Retirement Fund Has $281.24 Million Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 22 at 9:33 PM
Pfizer (PFE) Rises Higher Than Market: Key FactsPfizer (PFE) Rises Higher Than Market: Key Facts
zacks.com - April 22 at 6:51 PM
3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years
investorplace.com - April 22 at 5:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Boeing logo

Boeing

NYSE:BA
The Boeing Company, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch systems, and services worldwide. The company operates through Commercial Airplanes; Defense, Space & Security; and Global Services segments. The Commercial Airplanes segment develops, produces, and markets commercial jet aircraft for passenger and cargo requirements, as well as provides fleet support services. The Defense, Space & Security segment engages in the research, development, production, and modification of manned and unmanned military aircraft and weapons systems; strategic defense and intelligence systems, which include strategic missile and defense systems, command, control, communications, computers, intelligence, surveillance and reconnaissance, cyber and information solutions, and intelligence systems; and satellite systems, such as government and commercial satellites, and space exploration. The Global Services segment offers products and services, including supply chain and logistics management, engineering, maintenance and modifications, upgrades and conversions, spare parts, pilot and maintenance training systems and services, technical and maintenance documents, and data analytics and digital services to commercial and defense customers. The Boeing Company was incorporated in 1916 and is based in Arlington, Virginia.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.